Attovia Therapeutics, Inc. (ATTO) Expected Move

Expected move estimates the probable price range for a given period based on at-the-money options pricing. It reflects the market consensus for volatility over the selected timeframe.

Attovia Therapeutics, Inc. (ATTO) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $890.7M, listed on NASDAQ, employing roughly 44 people, carrying a beta of 0.00 to the broader market. A clinical-stage biopharmaceutical company developing biotherapeutics for immune-mediated diseases using its ATTOBODY biologics platform. Led by Tao Fu, public since 2026-08-05.

Expected move analysis estimates the probable price range implied by options pricing. No recent options activity for ATTO as of 2026-08-31; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how expected move is reported and how to read the data →